Maureen Lefton-Greif, PhD
Two goals of this study are to develop non-invasive markers that will (1) lessen the impact of swallowing dysfunction by facilitating early identification of oropharyngeal dysphagia for the prompt initiation of appropriate treatment and (2) serve as biomarkers for disease progression or clinical trials
6 years or older and able to participate in procedures for recordings of respiration during swallowing and phonation; previously evaluated at the A-T Clinical Center at Hopkins or must provide medical records that confirm the diagnosis of A-T.
Participants recruited only during regularly scheduled A-T Clinical Center visits or meetings for patients with A-T.
No immediate benefit to participants but may help medical treatment in the future.